Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00210-023-02807-9.pdf
Reference25 articles.
1. Arnold M, Morgan E, Rumgay H et al (2022) Current and future burden of Breast cancer: global statistics for 2020 and 2040. The Breast 66:15–23. https://doi.org/10.1016/j.breast.2022.08.010
2. Chou T-C (2014) Frequently asked questions in drug combinations and the mass-action law-based answers. Synergy 1:3–21. https://doi.org/10.1016/j.synres.2014.07.003
3. Chou T-C (2018) The combination index (CI < 1) as the definition of synergism and of synergy claims. Synergy 7:49–50. https://doi.org/10.1016/j.synres.2018.04.001
4. Dalmases A et al (2014) Deficiency in P53 is required for doxorubicin induced transcriptional activation of NF-КB target genes in human breast cancer. Oncotarget 5(1):196–210.
5. Feng Y, Spezia M, Huang S et al (2018) Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 5:77–106. https://doi.org/10.1016/j.gendis.2018.05.001
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antagonistic interaction of HSP90 inhibitor XL-888 and 5-FU combination treatment in breast cancer cells;International Advanced Researches and Engineering Journal;2024-08-07
2. Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line;Medical Oncology;2024-07-03
3. A study with cancer stem cells and three-dimensional tumoroids: investigation of the combined effects of 5-fluorouracil and doxorubicin in breast cancer;Medical Oncology;2024-06-23
4. Metabolomic Profiling of Leptadenia reticulata: Unveiling Therapeutic Potential for Inflammatory Diseases through Network Pharmacology and Docking Studies;Pharmaceuticals;2024-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3